Document is current

Article History

Received: 13 December 2021

Revised: 12 April 2022

Accepted: 13 April 2022

First Online: 13 May 2022

Declarations

:

: <i>S Iida</i> has received a research grant and compensation as a member of the scientific advisory board of Sanofi K.K during the production of this article; outside the submitted work; has received grants and personal fees from Janssen, Celgene, Takeda, Ono, Daiichi Sankyo, Bristol-Myers Squibb, and personal fees from GlaxoSmithKline, AbbVie, Chugai, and Kyowa Kirin. <i>T Ishida</i> has received compensation as a member of the scientific advisory board of Sanofi K.K, and personal fees from Takeda, Ono, Bristol Myers Squibb, and Janssen during the conduct of this study. <i>S Teramukai</i> reports payments outside the submitted article through grants from Nippon Boehringer Ingelheim and personal fees from Daiichi Sankyo, Sanofi K.K., Takeda, Bayer Yakuhin, Sysmex, Chugai, Solasia, Nipro, Atworking, NapaJen Pharma, and Gunze. <i>T Teshima</i> has received compensation as a member of the scientific advisory board of Sanofi K.K during the conduct of this study; and outside the submitted work has received grants, personal fees, and non-financial support from Novartis, grants and personal fees from Kyowa Kirin, grants from Chugai, Astellas, Teijin Pharma, Fuji Pharma, Nippon Shinyaku, personal fees from Merck Sharp & Dohme, Takeda, Pfizer, Bristol-Myers Squibb, and non-financial support from Janssen. <i>H Shirai</i>, <i>R Kanamori</i>, and <i>Y Tajima</i> are employees of Sanofi K.K. <i>B Crawford</i> and <i>J Yi</i> are employees of Syneos Health. <i>T Miyamoto</i> reports no conflicts of interest.